Treatment of the following infections when caused by susceptible strains of the designated microorganisms:
Bacterial sinusitis caused by Streptococci, S. pneumoniae and Staphylococcus aureus (methicillin-sensitive only).
Respiratory tract infections caused by S. pneumoniae and group A β-haemolytic Streptococci. (Penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. Cephalexin is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin in the subsequent prevention of rheumatic fever are not available at present.)
Otitis media due to S. pneumoniae, H. influenzae, staphylococci, streptococci and M. catarrhalis.
Skin and soft tissue infections caused by staphylococci and/or streptococci.
Bone infections caused by staphylococci and/or P. mirabilis.
Genitourinary tract infections, including acute prostatitis, caused by E. coli, P. mirabilis and Klebsiella sp.
Dental infections caused by staphylococci and/or streptococci.
Note: Culture and susceptibility tests should be initiated prior to and during therapy. Renal function studies should be performed when indicated.
Sign Out